1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLAN-1-YL)BENZENE, 98%, 100mg

4,5-Dichloropicolinic acid, 95.0%, 5g

1-(5-Bromofuran-2-yl)ethan-1-one, 95+%, 1g

ETHYL 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLATE, 95.0%, 5g

GC capillary column ROTI®Cap-5 MS Ultra, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

Pritelivir, 99.03%, 5mg

1,4,5,6-Tetrahydropyrimidin-2-amine hydrochloride, 95.0%, 250mg

N,N-Diethylaniline , >=98.5 %, for synthesis, 2.5 L, glass packaging

Methyl trans-3-amino-cyclobutanecarboxylate hydrochloride, 97%, 25g

tert-Butyl 4-(3-aminophenyl)piperidine-1-carboxylate, 95.0%, 250mg

3-Amino-4-(1H-pyrazol-1-yl)benzoic acid, 95%, 500mg

2-(2-Chlorophenoxy)acetamide, 98%, 5g

3-Cyclopropylpyridin-2-amine, 95.0%, 1g